A case of autoimmune haemolytic anaemia after 39 cycles of nivolumab

With growing use of nivolumab, rare but serious side effects have surfaced in some patients. We present a case of autoimmune haemolytic anaemia that developed after 39 cycles of nivolumab. A 78-year-old man with metastatic lung adenocarcinoma, refractory to multiple lines of chemotherapy was switche...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Shaikh, Hira, Daboul, Nour, Albrethsen, Mary, Fazal, Salman
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2018
Gaiak:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5911145/
https://ncbi.nlm.nih.gov/pubmed/29669775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-224608
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak